Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PASG
PASG
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PASG News
Biotech Sector Update: FDA and EU Approvals
Jun 26 2026
NASDAQ.COM
Passage Bio and Remix Therapeutics Announce Merger Agreement
Jun 25 2026
NASDAQ.COM
ARS Pharmaceuticals Faces Insurance Coverage Setback
Jun 25 2026
stocktwits
Remix and Passage Bio Merger Details Unveiled
Jun 24 2026
stocktwits
Passage Bio and Remix Therapeutics Announce Merger Agreement
Jun 24 2026
seekingalpha
Passage Bio Reports Q4 2025 Financial Results
Mar 03 2026
seekingalpha
Top Analysts Recommend 3 Biotech Stocks to Purchase Now, 11/12/2025
Nov 12 2025
TipRanks
PASSAGE BIO, INC. Reports Reduced Q3 Loss, Surpassing Expectations
Nov 11 2025
NASDAQ.COM
Passage Bio Announces Financial Results for Q3 2025 and Shares Recent Business Updates
Nov 10 2025
Newsfilter
Wall Street Analysts Predict Passage Bio (PASG) Could Soar by 731%: Important Insights Before You Invest
Sep 01 2025
NASDAQ.COM
Guggenheim Maintains Buy on Passage Bio, Lowers Price Target to $10
Aug 14 2025
Benzinga
Upcoming Stock Splits This Week (July 14 to July 18) – Stay Invested
Jul 13 2025
TipRanks
Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights
May 13 2025
Newsfilter
Analysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX), Black Diamond Therapeutics (BDTX) and Passage Bio (PASG)
Mar 07 2025
Business Insider
Chardan Capital Maintains Buy on Passage Bio, Lowers Price Target to $6
Mar 04 2025
Benzinga
Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights
Mar 04 2025
Newsfilter
Show More News
